JAMA analysis stirs debate

A JAMA analysis questioning the effectiveness of antidepressants has renewed debate.

The meta-analysis found that antidepressents are useful for those with severe depression symptoms but don't work any better than placebo in mild cases. In a letter to The New York Times, Weill Cornell psychiatry professor Dr. Richard Friedman derided the research for including only two drugs and for excluding studies that screened out placebo responders.

Two of the researchers defended their methodology, saying many approved antidepressants vary little in effectiveness and that their aim was to estimate effects of medications vs. placebos.

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.